Related references
Note: Only part of the references are listed.Prognostic value of the myocardial salvage index measured by T2-weighted and T1-weighted late gadolinium enhancement magnetic resonance imaging after ST-segment elevation myocardial infarction: A systematic review and meta-regression analysis
Benjamin Kendziora et al.
PLOS ONE (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials JACC Scientific Expert Panel
Borja Ibanez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction
Edina Cenko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury JACC Review Topic of the Week
Sean M. Davidson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M. Alvi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Anne Kristine Anstensrud et al.
OPEN HEART (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Impact of Cardioprotective Therapies on the Edema-Based Area at Risk by CMR in Reperfused STEMI
Heerajnarain Bulluck et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
MethotrexaTE THerapy in ST-Segment Elevation MYocardial InfarctionS: A Randomized Double-Blind, Placebo-Controlled Trial (TETHYS Trial)
Daniel Medeiros Moreira et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial+
Ola Kleveland et al.
EUROPEAN HEART JOURNAL (2016)
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
Peter C. Westman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Relationship Between Infarct Size and Outcomes Following Primary PCI Patient-Level Analysis From 10 Randomized Trials
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
David Nordlund et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
Henrik Engblom et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2016)
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Derek J. Hausenloy et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The quantification of infarct size
RJ Gibbons et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
EC Keeley et al.
LANCET (2003)
Share Paper
